(Q38255352)

1 September 2017

Linezolid for Treating Tuberculosis: A Delicate Balancing Act. (English)

1 reference

1 September 2017

1 reference

1 reference

Gary Maartens

1

0 references

author name string

Constance A Benson

series ordinal

2

1 reference

1 September 2017

21 October 2015

1 reference

1 September 2017

1 reference

1 September 2017

2

1 reference

1 September 2017

11

1 reference

1 September 2017

1568-1569

1 reference

Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis

1 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740312

Nonclinical and pharmacokinetic assessments to evaluate the potential of tedizolid and linezolid to affect mitochondrial function

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740312

Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740312

Linezolid for treatment of chronic extensively drug-resistant tuberculosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740312

Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740312

In vitro activities of DA-7157 and DA-7218 against Mycobacterium tuberculosis and Nocardia brasiliensis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740312

Linezolid-induced inhibition of mitochondrial protein synthesis.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4740312

Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China

31 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26870767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26870767

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.EBIOM.2015.10.014

1 reference

1 September 2017

1 reference

1 September 2017

1 reference

PMCID

4740312